The following trial are currently enrolling.  For more information, click on the link to ClinicalTrials.gov or call the number indicated.

NCT Identifier

Study Title

UAB Investigator

Study Coordinator

NCT01760005

DIAN-TU: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation

Dr. Roberson

Amber Watkins

205-934-0946

NCT02365922

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

 Dr. Roberson

Emily McKinley

205 -996-3659

NCT02854033

Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol (ADNI3)-Cognitively Normal/ Mild cognitive Impairment/Mild Alzheimer’s Disease dementia.

Dr. Geldmacher

Loren Ashley

205-975-2779


The following trials are no longer recruiting.

NCT Identifier

Study Title

UAB Investigator

NCT02985879 A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Progressive Supranuclear Palsy Dr. Geldmacher
NCT03088956
Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD) (FORWARD) Dr. Roberson
NCT02615002 Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION) Dr. Geldmacher
NCT02569398

An Efficacy and Safety Study of JNJ-54861911 in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia (EARLY) Dr. Geldmacher
NCT02484547 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (EMERGE) Dr. Geldmacher
NCT02420756 Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study (IDEAS) Dr. Roberson
NCT02008357 A4: Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Dr. Geldmacher
NCT02167594 A09: Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers Dr. Roberson
NCT01767311 A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease Dr. Geldmacher
NCT01955161 STARSHINE: Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil Dr. Geldmacher
NCT02494024 A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects with Progressive Supranuclear Palsy Dr. Roberson
NCT02460094 A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy Dr. Geldmacher
NCT02133846 TPI-287-4RT: Safety Study of TPI-287 to Treat CBS and PSP Dr. Roberson
NCT02534038 Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition Dr. Geldmacher